Assessment of neuropharmacological consequences induced by dexamethasone administration in rats model of neurodegenerative diseases.


Journal

Pakistan journal of pharmaceutical sciences
ISSN: 1011-601X
Titre abrégé: Pak J Pharm Sci
Pays: Pakistan
ID NLM: 9426356

Informations de publication

Date de publication:
Nov 2023
Historique:
medline: 21 12 2023
pubmed: 21 12 2023
entrez: 21 12 2023
Statut: ppublish

Résumé

Stress is a well-known and frequently used term among present generation. It has been referred to the response of body to any challenge for a change. It is a natural process and our body is designed to cope with it. However, if stress becomes chronic, it can lead to mental health problems. Stress due to the prolonged administration of glucocorticoid is enabled to produce impressive alterations in rats model shoeing depressive like behavior. In this investigation; purpose was to study the impact of episodic treatment of dexamethasone with respect to behavioral changes in rats. It was hypothesized that repeated administration of dexamethasone could increase stress and thus, psychological stress leading to mood disorders and behavior deficits in rats. Rats were injected daily with DEX (10 mg/ml/kg, orally) and the different behavioral models of the animals were assessed. DEX-treated rats exhibited depressive behavior like greater time to start mobility in a novel environment and elevated anxiety-like behavior in elevated plus maze. However, time spent in light compartment was shorter with repeated administration of DEX. From results it is demonstrated that the administration of DXM for weeks induced stress and consequently, induced a depression-like behaviors in rats models.

Identifiants

pubmed: 38124413

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1735-1741

Auteurs

Muhammad Farhan (M)

Neurochemistry and Biochemical Neuropharmacology Research Unit Department of Biochemistry, University of Karachi, Karachi, Pakistan.

Samia Khan (S)

Neurochemistry and Biochemical Neuropharmacology Research Unit Department of Biochemistry, University of Karachi, Karachi, Pakistan.

Ayesha Ahmed Soomro (A)

Neurochemistry and Biochemical Neuropharmacology Research Unit Department of Biochemistry, University of Karachi, Karachi, Pakistan.

Shoaib Ahmed (S)

Department of Biochemistry, Federal Urdu University of Science and Technology, Karachi, Pakistan.

Anila Bibi (A)

Departments of Biochemistry, Jinnah Sindh Medical University, Karachi, Pakistan.

Syeda Rabab Zehra (S)

Neurochemistry and Biochemical Neuropharmacology Research Unit Department of Biochemistry, University of Karachi, Karachi, Pakistan.

Maria Arshad (M)

Neurochemistry and Biochemical Neuropharmacology Research Unit Department of Biochemistry, University of Karachi, Karachi, Pakistan.

Fatima Riaz (F)

Neurochemistry and Biochemical Neuropharmacology Research Unit Department of Biochemistry, University of Karachi, Karachi, Pakistan.

Sadia Rehman (S)

Department of Biochemistry, Bahria University of Health Sciences, Karachi, Pakistan.

Saher Asif (S)

Neurochemistry and Biochemical Neuropharmacology Research Unit Department of Biochemistry, University of Karachi, Karachi, Pakistan.

Classifications MeSH